Copies: This document is available on the World Wide Web sites of the American College of
Cardiology (http://www. cardiosource. org), the American Association for Thoracic Surgery (…

Drug-Eluting Coronary-Artery Stents | NEJM Skip to main content NEJM Group Follow Us
Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …

… Schwartz RS, Murphy IG, Edwards WO, Camrud AR, Vlietstra RE, Holmes DR. Restenosis
after … Holmes DR Jr. Very early prediction of restenosis after successful coronary angioplasty: …

Background Preliminary reports of studies involving simple coronary lesions indicate that a
sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary …

Background Percutaneous coronary intervention (PCI) involving drug-eluting stents is
increasingly used to treat complex coronary artery disease, although coronary-artery bypass …

The recommendations listed in this CPG are, whenever possible, evidence based. An extensive
evidence review was conducted through October 2012, and other selected references …

Background—Coronary endothelial dysfunction is characterized by vasoconstrictive response
to the endothelium-dependent vasodilator acetylcholine. Although endothelial dysfunction …

Background— In patients undergoing percutaneous coronary intervention (PCI) in the modern
era, the incidence and prognostic implications of acute renal failure (ARF) are unknown. …

Background In patients with non-valvular atrial fibrillation, embolic stroke is thought to be
associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of …

Background We report the 5-year results of the SYNTAX trial, which compared coronary
artery bypass graft surgery (CABG) with percutaneous coronary intervention (PCI) for the …